These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. Strübing C; Hering S; Glossmann H Br J Pharmacol; 1993 Apr; 108(4):884-91. PubMed ID: 7683566 [TBL] [Abstract][Full Text] [Related]
24. Different potencies of dihydropyridine derivatives in blocking T-type but not L-type Ca2+ channels in neuroblastoma-glioma hybrid cells. Stengel W; Jainz M; Andreas K Eur J Pharmacol; 1998 Jan; 342(2-3):339-45. PubMed ID: 9548406 [TBL] [Abstract][Full Text] [Related]
25. Calcium channels in solitary retinal ganglion cells from post-natal rat. Karschin A; Lipton SA J Physiol; 1989 Nov; 418():379-96. PubMed ID: 2559971 [TBL] [Abstract][Full Text] [Related]
27. Calcium channel subtypes in lamprey sensory and motor neurons. El Manira A; Bussières N J Neurophysiol; 1997 Sep; 78(3):1334-40. PubMed ID: 9310424 [TBL] [Abstract][Full Text] [Related]
28. Volatile anesthetics reduce low-voltage-activated calcium currents in a thyroid C-cell line. McDowell TS; Pancrazio JJ; Lynch C Anesthesiology; 1996 Nov; 85(5):1167-75. PubMed ID: 8916835 [TBL] [Abstract][Full Text] [Related]
29. Neurotensin and substance P inhibit low- and high-voltage-activated Ca2+ channels in cultured newborn rat nucleus basalis neurons. Margeta-Mitrovic M; Grigg JJ; Koyano K; Nakajima Y; Nakajima S J Neurophysiol; 1997 Sep; 78(3):1341-52. PubMed ID: 9310425 [TBL] [Abstract][Full Text] [Related]
30. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. Furukawa T; Yamakawa T; Midera T; Sagawa T; Mori Y; Nukada T J Pharmacol Exp Ther; 1999 Nov; 291(2):464-73. PubMed ID: 10525060 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous and corticotropin-releasing factor-induced cytosolic calcium transients in corticotrophs. Guérineau N; Corcuff JB; Tabarin A; Mollard P Endocrinology; 1991 Jul; 129(1):409-20. PubMed ID: 1647305 [TBL] [Abstract][Full Text] [Related]
32. Effects of dichlorobenzamil on calcium currents in clonal GH3 pituitary cells. Suarez-Kurtz G; Kaczorowski GJ J Pharmacol Exp Ther; 1988 Oct; 247(1):248-53. PubMed ID: 2845054 [TBL] [Abstract][Full Text] [Related]
33. Lercanidipine and T-type calcium current. Cerbai E; Mugelli A Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):4025-4031. PubMed ID: 29949180 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of ATP-induced surfactant exocytosis by dihydropyridine (DHP) derivatives: a non-stereospecific, photoactivated effect and independent of L-type Ca2+ channels. Frick M; Siber G; Haller T; Mair N; Dietl P Biochem Pharmacol; 2001 May; 61(9):1161-7. PubMed ID: 11301050 [TBL] [Abstract][Full Text] [Related]
35. Voltage-dependent currents and modulation of calcium channel expression in zona fasciculata cells from rat adrenal gland. Barbara JG; Takeda K J Physiol; 1995 Nov; 488 ( Pt 3)(Pt 3):609-22. PubMed ID: 8576852 [TBL] [Abstract][Full Text] [Related]
36. Low- and high-voltage-activated calcium channel currents and their modulation in the dorsal root ganglion cell line ND7-23. Kobrinsky EM; Pearson HA; Dolphin AC Neuroscience; 1994 Feb; 58(3):539-52. PubMed ID: 7909587 [TBL] [Abstract][Full Text] [Related]
37. Regulation of Ca2+-activated nonselective cationic currents in rat pituitary GH3 cells: involvement in L-type Ca2+ current. Wu SN; Li HF; Jan CR Brain Res; 1998 Nov; 812(1-2):133-41. PubMed ID: 9813284 [TBL] [Abstract][Full Text] [Related]